483 Novartis Pharma AG Aug 2019

483 Novartis Pharma AG Aug 2019

$119 - Not in Stock

FDA investigators audited the Novartis Pharma AG - Basel, Switzerland facility and issued inspectional observations (via FDA 483) on 29 Aug 2019.

Product details

  • Category: Human Drugs
  • Inspection end: 29 Aug 2019
  • Location: Basel, Switzerland
  • FEI: 3002807772

Pre-Order Not Available